|
|
||||||||
1 Institute for Medical Psychology, Faculty of Medicine, University of Essen, 45122 Essen, 3 Division of Functional and Applied Anatomy, Hannover Medical School, 30623 Hannover, Germany; and 2 Department of Psychology, University of Newcastle, Ourimbah, Australia 2258
| |
ABSTRACT |
|---|
|
|
|---|
The present study investigated the role of sympathetic innervation of the spleen in conditioned suppression of a contact hypersensitivity (CHS) reaction. Behavioral conditioning was achieved by pairing saccharin drinking solution (conditioned stimulus, CS) with injection of cyclosporin A (CsA, 20 mg/kg; unconditioned stimulus, UCS). Four days after sensitization of the animals by application of a 5% 2,4-dinitrochlorobenzene (DNCB) to abdominal skin, the animals were challenged by applying a 1% DNCB solution to the ear. The CHS response was monitored by measuring the degree of ear swelling. Saccharin re-presentation reduced ear swelling to a magnitude that approached that achieved by CsA treatment. Histological examination demonstrated that the conditioned reduction of ear swelling was produced by a reduced leukocyte infiltration of the ear. Prior sympathetic denervation of the spleen did not alter the conditioned suppression of the CHS response. These data indicate that behavioral conditioning using CsA produces alterations of CHS that, unlike conditioned prolongation of heart allograft survival, are independent of sympathetically regulated conditioned alterations in the spleen.
classical conditioning; cyclosporin
| |
INTRODUCTION |
|---|
|
|
|---|
BEHAVIORAL OR CLASSICAL CONDITIONING is an associative learning paradigm, which pairs presentation of a benign novel stimulus (conditioned stimulus, CS) with a stimulus that produces physiological changes (unconditioned stimulus, UCS). Upon re-presentation of the CS, the organism produces physiological alterations that are usually ascribed to the UCS. This paradigm has been implemented to produce conditioned alterations in immune functions (1). Commonly, animals are presented with a sweet taste (saccharin) in the drinking water and subsequently injected with a pharmacological agent that produces changes in immune status. At a later date, the saccharin solution is re-presented, with the animals avoiding the stimulus (conditioned taste aversion) and experiencing concomitant alterations in immune function concordant with the effect of actual drug administration.
We established a model of behavioral conditioning that pairs saccharin
as the CS with cyclosporin A (CsA) as the UCS (9, 10, 29).
This paradigm produces conditioned reduction of splenocyte proliferation and cytokine [interleukin (IL)-2, interferon (IFN)-
] synthesis in the spleen (9). These alterations are
biologically relevant, as the paradigm prolongs survival time of
heterotopic heart allografts (9, 10). Furthermore, the
immunological and transplantation effects observed previously are
mediated via sympathetic innervation of the spleen, as splenic
denervation completely blocks the conditioned changes (9,
10).
Therefore, to investigate whether the behavioral conditioning paradigm using CsA as a UCS is generalizable to other cell-mediated immune responses, we examined the effects of conditioning on the course of the murine model of allergic contact dermatitis, contact hypersensitivity (CHS) (21, 23). Furthermore, to investigate whether conditioned changes of immune function using the present model generally function via sympathetic innervation of the spleen (9, 10), we examined the conditionability of CHS suppression in animals with a denervated spleen.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Animals. Eighty experimentally naive male dark agouti (DA) rats (Harlan Laboratories, Borchen, Germany) weighing between 220 and 250 g were used. All rats were allowed to habituate for 3 wk before experimentation. Animals were individually housed in standard plastic-based laboratory cages (40 × 26 × 15-cm high) with a wire mesh lid. Cages were kept in an air-conditioned, sound-proofed holding room at an ambient temperature of 24.0 ± 0.5°C. The animals had access to standard lab chow and tap water ad libitum, except during the water-deprivation phase of the experiment. A 12:12-h light-dark cycle was maintained throughout the experiment, with lights off at 0700. This allowed stimuli presentation to be conducted during the dark (active) cycle of the animals. All conditioning procedures were completed under red light so as to avoid any interruption to the normal light-dark cycle of the rats.
Conditioning paradigm.
Male DA rats were placed on a water deprivation regimen for 5 days,
allowing them 15 min of drinking at 0700 and again at 1700 each day
(Fig. 1A). The present study
implemented a three learning (CS-UCS pairing) trial paradigm. Each
learning trial was separated by 72 h. This ensured that CsA was
completely metabolized between learning trials. On the 5th day, animals
received the first of three CS-UCS pairings. Twenty-four hours after
the final morning CS-UCS pairing, animals were sensitized with the
contact antigen 2,4-dinitrochlorobenzene (DNCB). Three days after the final pairing, the CS alone was presented during each drinking session.
This was repeated for the subsequent 2 days. One hour after the third
morning, CS re-presentation animals were challenged with the contact
antigen. Ear swelling was measured 24 h later.
|
Contact sensitivity. Contact sensitivity was induced by established methods (4, 17). Specifically, 200 µl of a 5% solution of DNCB (Sigma, St Louis, MO) dissolved in ethanol was applied to the shaven abdomen of the rat. Four days after sensitization, rats were challenged by the application of 20 µl of a 1% DNCB solution on each side of the right ear and 20 µl ethanol on each side of the left ear. Ear thickness was measured 24 h after challenge using a spring-loaded micrometer (Kroeplin, Schlüchtern, Germany) by an experimenter blind to the treatment groups. Ear swelling was recorded as the difference in ear thickness between the right and left ears and expressed in micrometers ± SE.
Splenic denervation. After the adaptation period, splenic denervation was conducted 2 wk before conditioning using standard techniques (9, 10). Briefly, a midline incision was used to open the abdominal cavity, exposing the splenic nerve vascular package. The splenic nerve bundle was isolated from the splenic vasculature, and the neural bundle was cut before its bifurcation. The incision was then sutured, and the animal was allowed to recover. Sham denervation was completed by again isolating the splenic nerve bundle without slicing the nerve.
Splenic catecholamine concentration. Denervation of the spleen was verified by measuring the level of splenic epinephrine and norepinephrine after measurement of ear swelling. Each spleen was homogenized in 0.1 M perchloric acid containing 0.1 mM EDTA. After centrifugation, 25 µl of the supernatant was used for catecholamine extraction (9). Norepinephrine concentrations were analyzed by HPLC (Gynkotek, Germany) and expressed as nanograms per gram wet tissue. Intra-assay variability was <10%.
Histology.
Both DNCB- and alcohol-treated ears were removed, frozen in liquid
nitrogen, and stored at
70°C. Cryostat sections were made (thickness = 5 µm), air dried, wrapped in aluminium foil, and stored at
20°C. The slides were fixed for 10 min in equal parts of
methanol and acetone (
20°C), washed in Tris-buffered saline containing 0.05% Tween 20, and incubated for 30 min at room
temperature in a moist chamber with a mouse anti-rat monoclonal
antibody to identify CD4+ and CD8+ T
lymphocytes, B lymphocytes, monocytes, and natural killer cells (30). Then the slides were incubated with the second-step
antibody (rabbit anti-mouse, Dako, Hamburg, Germany) and the third
mouse antibody complex alkaline phosphatase anti-alkaline phosphatase (Dako) for 30 min. To enhance stain intensity, the second and third
step antibody incubation steps were then repeated, each for 15 min
duration. The positive cells were subsequently revealed in blue using
Fast blue. After washing with Tris-buffered saline the slides
were counterstained with hematoxylin (Fluka, Buchs, Switzerland) and
mounted in glycergel (Dako).
Statistical analyses. Average differences in ear swelling between groups were analyzed using one-way ANOVA. Post hoc Fisher's least significant difference tests were implemented to examine specific differences between groups. Values are presented as means ± SE. Statistically significant differences are reported when P < 0.05.
| |
RESULTS |
|---|
|
|
|---|
Behavioral conditioning suppresses CHS response. Conditioned animals in the present paradigm avoid consumption of the saccharin stimulus after the first CS-UCS pairing (conditioned taste aversion) (9, 10, 29). Such a response indicates acquisition of the association between the two stimuli and was observed in the present series of experiments, with conditioned animals typically drinking <10% of the level of saccharin consumed by control animals (data not shown).
Behavioral conditioning reduced DNCB-induced ear swelling compared with sham-conditioned animals. The magnitude of suppression approached that observed in rats administered a short-course therapeutic regimen of CsA (Fig. 2). Histological examination confirmed that the reduction of ear swelling in CsA-treated and conditioned animals was produced by an inhibition of leukocyte infiltration into the ear (Fig. 3). No differences in specific leukocyte subset infiltration were observed (data not shown).
|
|
Conditioned suppression of CHS response is not mediated by
sympathetic innervation of the spleen.
Because we demonstrated that behaviorally conditioned prolongation of
heart allograft survival is mediated via sympathetic innervation of the
spleen (10), we examined the role of splenic innervation in suppression of the CHS response. Compared with sham-denervated rats, surgical denervation reduced splenic epinephrine and norepinephrine content to <20 and <10%, respectively (Fig. 4). Denervation per se had no effect on
ear swelling, as no difference was observed between sham-conditioned
animals that were either denervated or sham denervated. Additionally,
surgical denervation of the spleen did not abrogate the behaviorally
conditioned suppression of ear swelling (Fig.
5).
|
|
| |
DISCUSSION |
|---|
|
|
|---|
The behavioral conditioning paradigm used presently suppresses
splenocyte proliferation and production of Th1 cytokines (IL-2 and
IFN-
) (9). Furthermore, these changes in cellular
immune function are of sufficient magnitude to extend survival time of transplanted organs (9, 10). The current data demonstrate that conditioned changes are able to suppress the development of
another T cell-mediated immune response, namely, contact sensitivity to
haptens. However, in contrast to conditioned prolongation of heart allograft survival, the conditioned suppression of contact hypersensitivity is independent of sympathetic innervation of the
spleen, as splenic denervation did not abrogate the conditioned effect.
The conditioned suppression of contact sensitivity using CsA as a UCS
demonstrates that the conditioned effect is generalizable to other
cell-mediated immune responses. Contact hypersensitivity is dependent
on T cell IL-2, tumor necrosis factor (TNF)-
, and IFN-
production
(8, 31, 32). As we have shown that the present paradigm
suppresses splenocyte IL-2 and IFN-
production, it is likely that
conditioning reduces contact sensitivity via inhibition of production
of these cytokines.
We have shown that the functionally relevant suppression of cytokine
production in the spleen is mediated via sympathetic innervation.
Sympathetic nerves are in close contact with lymphocytes in the spleen
(11, 19), and they release catecholamines that influence
splenic IL-6, IL-2, and IFN-
production (26) via functional adrenoceptors (18, 25). Therefore, we examined whether the conditioned suppression of IL-2 and IFN-
production of
splenocytes also contributes to development of conditioned reduction in
contact sensitivity. Splenic denervation did not alter the conditioned
suppression of contact sensitivity, indicating that conditioning alters
immune changes via a number of simultaneous mechanisms.
The acute elicitation phase of contact sensitivity used presently is
relatively independent of immune function of the spleen (12, 13,
16, 31). Specifically, challenge with the hapten results in
CD4+ and CD8+ T cell infiltration of the
draining lymph nodes; production of IFN-
, IL-2, and TNF-
;
recruitment of other inflammatory cells; and subsequent infiltration to
the challenge site resulting in the characteristic edema (5, 8,
27, 31). Although the primary immune response to sensitization
is partially regulated by the production of IFN-
, IL-2, and IL-12 in
the spleen (2, 20), the acute secondary immune response
occurs primarily in draining lymph nodes, independent of splenic
cytokine production (12, 13, 16, 31). Thus the present
data show that conditioning has altered immune function specific to
contact sensitivity inflammation.
The mechanisms whereby conditioning achieves a suppression of contact sensitivity are unclear. We have shown that conditioned alterations of cellular immunity in the spleen are mediated via sympathetic innervation (9, 10). As lymph nodes are also innervated by sympathetic nerves (11, 19), it is possible that conditioning may suppress the inflammatory response via neural innervation of the draining lymph nodes. In contrast, we cannot rule out the possibility that humoral mediators produce the current effects. High levels of corticosterone suppress, where mild stress-induced elevations of corticosterone enhance CHS after challenge (6, 7). Furthermore, as stress-induced alterations of CHS are abrogated by adrenalectomy (7), the current suppression of CHS may have been produced by adrenal hormones. However, as we have not been able to find any changes in corticosterone levels in response to the current paradigm, this seems unlikely. Nevertheless, it must be considered that other neuroendocrine factors may play a role in producing conditioned suppression of CHS (3, 14, 22, 28).
Conditioning produced a reduction of leukocyte infiltration of the
challenged ear. This may have been produced by a number of mechanisms.
First, conditioning may have suppressed the proliferation of T cells in
lymph nodes, mimicking the effect of CsA (21, 23, 24).
However, the swelling of cell numbers in draining lymph nodes during
the CHS reaction is due primarily to cellular infiltration rather than
proliferation (8, 27). Therefore, conditioning may have
suppressed T cell production of IL-2, IFN-
, and TNF-
in draining
lymph nodes, thus reducing cellular infiltration to the challenged ear
(5, 8, 31). Alternatively, conditioning may have
suppressed chemokine-regulated recruitment of T cells from peripheral
blood to the lymph nodes (15, 27). Thus examination of
draining lymph node and peripheral blood cytokine profiles is required
to help elucidate the mechanism of conditioned CHS suppression.
In summary, the current data show that behavioral conditioning can mimic the CsA-induced suppression of a CHS response. In contrast to prolongation of heart allograft survival, this effect is independent of sympathetic innervation of the spleen. This suggests that the current paradigm has the ability to reproduce changes in immune function that are predominantly not mediated by changes in the spleen. Nevertheless, it is presently unclear whether this is also produced by neural innervation of draining lymph nodes or via other endocrine factors in peripheral blood.
| |
ACKNOWLEDGEMENTS |
|---|
This work was supported by grants I/70 485 from the Volkswagen Foundation (to M. Schedlowski and J. Westermann) and the German Research Foundation (341/9-1). CsA was kindly donated by Novartis (Nürnberg, Germany).
| |
FOOTNOTES |
|---|
Address for reprint requests and other correspondence: M. Exton, Institute of Medical Psychology, Univ. Clinic Essen, Hufelandstr. 55, D-45122 Essen, Germany (E-mail: michael.exton{at}uni-essen.de).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 8 February 2000; accepted in final form 17 May 2000.
| |
REFERENCES |
|---|
|
|
|---|
1.
Ader, R,
and
Cohen N.
Psychoneuroimmunology: conditioning and stress.
Annu Rev Psychol
44:
53-85,
1993[Web of Science][Medline].
2.
Bellinghausen, I,
Brand U,
Enk AH,
Knop J,
and
Saloga J.
Signals involved in the early TH1/TH2 polarization of an immune response depending on the type of antigen.
J Allergy Clin Immunol
103:
298-306,
1999[Web of Science][Medline].
3.
Berczi, I,
Nagy E,
Asa SL,
and
Kovacs K.
Pituitary hormones and contact sensitivity in rats.
Allergy
38:
325-330,
1983[Web of Science][Medline].
4.
Bunce, C,
and
Bell EB.
CD45RC isoforms define two types of CD4 memory T cells, one of which depends on persisting antigen.
J Exp Med
185:
767-776,
1997
5.
Dearman, RJ,
Moussavi A,
Kemeny DM,
and
Kimber I.
Contribution of CD4+ and CD8+ T lymphocyte subsets to the cytokine secretion patterns induced in mice during sensitization to contact and respiratory chemical allergens.
Immunology
89:
502-510,
1996[Web of Science][Medline].
6.
Dhabhar, FS,
and
McEwen BS.
Stress-induced enhancement of antigen-specific cell-mediated immunity.
J Immunol
156:
2608-2615,
1996[Abstract].
7.
Dhabhar, FS,
and
McEwen BS.
Enhancing versus suppressive effects of stress hormones on skin immune function.
Proc Natl Acad Sci USA
96:
1059-1064,
1999
8.
Enk, AH,
and
Katz SI.
Early molecular events in the induction phase of contact sensitivity.
Proc Natl Acad Sci USA
89:
1398-1402,
1992
9.
Exton, MS,
von Hörsten S,
Schult M,
Vöge J,
Strubel T,
Donath S,
Steinmüller C,
Seeliger H,
Nagel E,
Westermann J,
and
Schedlowski M.
Behaviorally conditioned immunosuppression using cyclosporin A: central nervous system reduces IL-2 production via splenic innervation.
J Neuroimmunol
88:
182-191,
1998[Web of Science][Medline].
10.
Exton, MS,
Schult M,
Donath S,
Strubel T,
Bode U,
del Rey A,
Westermann J,
and
Schedlowski M.
Conditioned immunosuppression makes subtherapeutic cyclosporin effective via splenic innervation.
Am J Physiol Regulatory Integrative Comp Physiol
276:
R1710-R1717,
1999
11.
Felten, DL,
Felten SY,
Bellinger DL,
Carlson SL,
Ackerman KD,
Madden KS,
Olschowka JA,
and
Livnat S.
Noradrenergic sympathetic neural interactions with the immune system: structure and function.
Immunol Rev
100:
225-260,
1987[Web of Science][Medline].
12.
Fujisawa, H,
Kondo S,
Wang B,
Shivji GM,
and
Sauder DN.
The role of CD4 molecules in the induction phase of contact hypersensitivity cytokine profiles in the skin and lymph nodes.
Immunology
89:
250-255,
1996[Web of Science][Medline].
13.
Garssen, J,
Vandebriel RJ,
de Gruijl FR,
Wolvers DAW,
van Dijk M,
and
Fluitman A.
UVB exposure-induced systemic modulation of Th1- and Th2-mediated immune responses.
Immunology
97:
506-514,
1999[Web of Science][Medline].
14.
Grabbe, S,
Bhardwaj RS,
Mahnke K,
Simon MM,
Schwarz T,
and
Luger TA.
-Melanocyte stimulating hormone induces hapten-specific tolerance in mice.
J Immunol
156:
473-478,
1996[Abstract].
15.
Gunn, MD,
Kyuwa S,
Tam C,
Kakiusci T,
Matsuzawa A,
Williams LT,
and
Nakano H.
Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization.
J Exp Med
189:
451-460,
1999
16.
Kitagaki, H,
Kimishima M,
Teraki Y,
Hayakawa J,
Hayakawa K,
Fujisawa S,
and
Shiohara T.
Distinct in vivo and in vitro cytokine profiles of draining lymph node cells in acute and chronic phases of contact hypersensitivity: importance of a type 2 cytokine-rich cutaneous milieu for the development of an early-type response in the chronic phase.
J Immunol
163:
1265-1273,
1999
17.
Klimuk, SK,
Semple SC,
Scherrer P,
and
Hope MJ.
Contact hypersensitivity: a simple model for the characterization of disease-site targeting by liposomes.
Biochim Biophys Acta
1417:
191-201,
1999[Medline].
18.
Kruszewska, B,
Felten SY,
and
Moynihan JA.
Alterations in cytokine and antibody production following chemical sympathectomy in two strains of mice.
J Immunol
155:
4613-4620,
1995[Abstract].
19.
Madden, KS,
Sanders VM,
and
Felten DL.
Catecholamine influences and sympathetic neural modulation of immune responsiveness.
Annu Rev Pharmacol Toxicol
35:
417-448,
1995[Web of Science][Medline].
20.
Müller, G,
Saloga J,
Germann T,
Schuler G,
Knop J,
and
Enk AH.
IL-12 as mediator and adjuvant for the induction of contact sensitivity in vivo.
J Immunol
155:
4661-4668,
1995[Abstract].
21.
Nagai, H,
Hiyama H,
Matsuo A,
Ueda Y,
Inagaki N,
and
Kawada K.
FK-506 and cyclosporin A potentiate the IgE antibody production by contact sensitization with hapten in mice.
J Pharmacol Exp Ther
283:
321-327,
1997
22.
Nagi, E,
and
Berczi I.
Prolactin and contact sensitivity.
Allergy
36:
429-431,
1981[Web of Science][Medline].
23.
Parker, D,
Drossler K,
and
Turk JL.
Kinetics of the effect of a single dose of cyclosporin-A on antibody and cell mediated immune responses in the guinea pig.
Int J Immunopharmacol
6:
67-74,
1984[Web of Science][Medline].
24.
Salerno, A,
Bonanno CT,
Caccamo N,
Cigna D,
Dominici R,
Ferro C,
Sireci G,
and
Dieli F.
The effect of cyclosporin A, KK506 and rapamycin on the murine contact sensitivity reaction.
Clin Exp Immunol
112:
112-119,
1998[Web of Science][Medline].
25.
Sanders, VM,
Baker RA,
Ramer-Quinn D,
Kasprowicz DJ,
Fuchs BA,
and
Street NE.
Differential expression of the
2-adrenergic receptor by Th1 and Th2 clones.
J Immunol
158:
4200-4210,
1997[Abstract].
26.
Straub, RH,
Westermann J,
Schölmerich J,
and
Falk W.
Communication between CNS and immune system in lymphoid organs: synaptic dialogue with macrophages and lymphocytes.
Immunol Today
19:
409-413,
1998[Web of Science][Medline].
27.
Telda, N,
Wang HW,
McNeil HP,
Di Girolamo N,
Hampartzoumian T,
Wakefield D,
and
Lloyd A.
Regulation of T lymphocyte trafficking into lymph nodes during an immune response by the chemokines macrophage inflammatory protein (MIP)-1
and MIP-1
.
J Immunol
161:
5663-5672,
1998
28.
Veronesi, B,
Williams WC,
Smialowicz RJ,
Sailstad DM,
Doerfler D,
and
Selgrade MJ.
Neuropeptide denervation alters both the elicitation and induction phases of contact hypersensitivity in mice.
Toxicol Appl Pharmacol
153:
243-249,
1998[Web of Science][Medline].
29.
Von Hörsten, S,
Exton MS,
Schult M,
Nagel E,
Stalp M,
Schweitzer G,
Vöge J,
del Rey A,
Schedlowski M,
and
Westermann J.
Behaviorally conditioned effects of cyclosporin A on the immune system of rats: specific alterations of blood leukocyte numbers and decrease of granulocyte function.
J Neuroimmunol
85:
193-201,
1998[Web of Science][Medline].
30.
Westermann, J,
and
Pabst R.
Autotransplantation of the spleen in the rat: donor leukocytes of the splenic fragment survive implantation to migrate and proliferate in the spleen.
Cell Tissue Res
287:
357-364,
1997[Web of Science][Medline].
31.
Xu, H,
DiIulio NA,
and
Fairchild RL.
T cell populations primed by hapten sensitization in contact sensitivity are distinguished by polarized patterns of cytokine production: interferon
-producing (Tc1) effector CD8+ T cells and interleukin (Il) 4/Il-10-producing (Th2) negative regulatory CD4+ T cells.
J Exp Med
183:
1001-1012,
1996
32.
Zaloom, Y,
Walsh LP,
McCulloch P,
and
Gallagher G.
Enhancement of a delayed hypersensitivity reaction to a contact allergen, by the systemic administration of interleukin-2.
Immunology
72:
584-587,
1991[Web of Science][Medline].
This article has been cited by other articles:
![]() |
G. Pacheco-Lopez, C. Riether, R. Doenlen, H. Engler, M.-B. Niemi, A. Engler, A. Kavelaars, C. J. Heijnen, and M. Schedlowski Calcineurin inhibition in splenocytes induced by pavlovian conditioning FASEB J, April 1, 2009; 23(4): 1161 - 1167. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Pacheco-Lopez, M.-B. Niemi, W. Kou, M. Harting, J. Fandrey, and M. Schedlowski Neural Substrates for Behaviorally Conditioned Immunosuppression in the Rat J. Neurosci., March 2, 2005; 25(9): 2330 - 2337. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. U. GOEBEL, A. E. TREBST, J. STEINER, Y. F. XIE, M. S. EXTON, S. FREDE, A. E. CANBAY, M. C. MICHEL, U. HEEMANN, and M. SCHEDLOWSKI Behavioral conditioning of immunosuppression is possible in humans FASEB J, December 1, 2002; 16(14): 1869 - 1873. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |